Johnson & Johnson Gain (Loss) on Disposition of Assets
Johnson & Johnson (JNJ) reported Gain (Loss) on Disposition of Assets of $1.20 billion for the 12-month period ending 2018-12-30, per its 10-K filed 2021-02-22.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-02-22
- Johnson & Johnson gain (loss) on disposition of assets for fiscal 2018 was $1.20B, a 7.69% decline from fiscal 2017.
- Johnson & Johnson gain (loss) on disposition of assets for fiscal 2017 was $1.30B, a 116.67% increase from fiscal 2017.
- Johnson & Johnson gain (loss) on disposition of assets for fiscal 2017 was $600.00M, a 76.92% decline from fiscal 2016.
- Johnson & Johnson gain (loss) on disposition of assets for fiscal 2016 was $2.60B, a 8.33% increase from fiscal 2014.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2018-12-30 | $1.20B 10-K · filed 2021-02-22 |
| 2017-12-31 | $1.30B 10-K · filed 2020-02-18 |
| 2017-01-01 | $600.00M 10-K · filed 2019-02-20 |
| 2016-01-03 | $2.60B 10-K · filed 2018-02-21 |
| 2014-12-28 | $2.40B 10-K · filed 2017-02-27 |
| 2013-12-29 | $100.00M 10-K · filed 2016-02-24 |
| 2012-12-30 | $900.00M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |